American Academy of Allergy, Asthma, & Immunology (AAAAI) 2023 | San Antonio

Watch highlights from the AAAAI 2023 Conference in San Antonio, TX, USA.

MD, MS

Theresa Guilbert +2 more

Past event

25February2023

Location

San Antonio, TX USA

Learning objectives

Examine interconnectivity between type 2 inflammation, barrier disruption, and clinical consequences of type 2 inflammatory diseases such as atopic dermatitis, asthma, and EoE
Understand onset and persistence of type 2 inflammation, and potential disease trajectories of atopic dermatitis, asthma, and EoE in pediatric patients

Description

Pediatric Type 2 Inflammatory Disease Progression
- Global experts Drs. Theresa Guilbert, Fred Ghali, and Jonathan Spergel discuss the role of type 2 inflammation in atopic dermatitis, asthma, and eosinophilic esophagitis in pediatric patients.

Location

San Antonio, TX USA

Speakers

Pulmonology

MD, MS

Theresa Guilbert

Professor | University of Cincinnati; Director of the Asthma Center | Cincinnati Children’s Hospital Medical Center, Ohio, United States

Dermatology

Fred Ghali

Adjunct Associate Professor of Dermatology | University of Texas Southwestern Medical School and Baylor Medical Department of Dermatology, Dallas, United States

Allergy/Immunology

MD, PhD

Jonathan Spergel

Professor of Pediatrics | Perelman School of Medicine, University of Pennsylvania; Chief of Allergy Section and Director of the Center for Pediatric Eosinophilic Disorders | Children’s Hospital of Philadelphia, Pennsylvania, United States

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: AustraliaChange country/region